What Researchers Did
Turkish doctors reported three newborn cases where HBOT was used as a last-resort treatment for life- or limb-threatening conditions including arterial blockage, blood clot with compartment syndrome, and a non-healing surgical wound.
What They Found
All three neonates received HBOT as an add-on to standard medical treatment. Outcomes included tissue salvage and improved wound healing in cases where standard treatment alone was insufficient. No serious HBOT-related adverse events were reported in any of the three infants.
Canadian Relevance
No direct Canadian connection identified. Neonatal HBOT is not a standard or OHIP-covered indication, but this report supports further investigation.
Study Limitations
Three cases are far too few to establish safety or efficacy; this report only demonstrates feasibility and calls for more structured research.